3D-printed phantoms for characterizing SERS nanoparticle detectability in turbid media

Andrew M Fales1, Pietro Strobbia, Tuan Vo-Dinh

  • 1Division of Biomedical Physics, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland 20993, USA. andrew.fales@fda.hhs.gov.

The Analyst
|August 9, 2020
PubMed
Summary

Developing 3D-printed phantoms helps evaluate surface-enhanced Raman scattering (SERS) tags for in vivo use. These phantoms reveal that SERS tag intensity in solution doesn't always predict performance in complex biological tissues.

Related Concept Videos